Market News
Stay updated with the latest market trends, earnings, and economic indicators.
CRISIL places Anupam Rasayan's credit ratings on watch
The ratings have been placed on watch following announcement by ARIL of acquisition of 43.3-48.2% equity stake in Bliss GVS Pharma, a pharmaceutical (pharma) formulations company based in India, which may be funded through debt, equity or internal accrual.
Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions
Bliss GVS Pharma shares have surged over 45% since the time it announced its deal with Anupam Rasayan. The WHO update is another positive news from the stock.
Modison Ltd leads gainers in 'B' group
Hitech Corporation Ltd, Bliss GVS Pharma Ltd, Biofil Chemicals & Pharmaceuticals Ltd and Indo Rama Synthetics (India) Ltd are among the other gainers in the BSE's 'B' group today, 26 May 2026.
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.
Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
Anupam Rasayan will acquire up to 74.2% stake in Bliss GVS Pharma, strengthening its presence across the pharmaceutical value chain and expanding its reach in regulated global markets.
Stocks to Watch Today: HDFC Bank, Yes Bank, Dabur, Senco Gold, Nykaa, Shakti Pumps, GK Energy, Rubicon Research, Manappuram, Enviro Infra in focus on 06 July
Stocks to Watch, 6 Jul: Stocks like HDFC Bank, Kotak Mahindra Bank, IndusInd Bank, Yes Bank, CreditAccess Grameen, RBL Bank, IDBI Bank, FSN E-Commerce Ventures Nykaa, Senco Gold, Dabur India, Godrej Consumer Products, GK Energy,Shakti Pumps (India), Innovision, PTC India, and Bliss GVS Pharma will be in focus on July 6.
Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore
Anupam Rasayan India Ltd reported a 40 percent rise in consolidated net profit at Rs 222.19 crore for 2025-26, compared with Rs 159.9 crore in the previous year.
Stocks to Watch Today: Infosys, Bliss GVS Pharma, Vedanta, John Cockerill, Concord Biotech, Rajnandini Fashion, Anand Rathi Wealth in focus on 03 June
Stocks to Watch, 03 June: Stocks like Infosys, Vedanta, Hindustan Zinc, Bliss GVS Pharma, Dhanuka Agritech, Advait Energy Transitions, John Cockerill India, Concord Biotech, InterGlobe Aviation, Rajnandini Fashion India, and Anand Rathi Wealth will be in focus on June 3.